by APFLI | Jun 17, 2015 | STDs
Abstract Background: Cervical cancer screening is one of the greatest cancer prevention achievements, yet some women still develop or die from this disease. Objective: To assess recent trends in cervical cancer incidence and mortality, current screening percentages,...
by APFLI | Jun 16, 2015 | Vaccines
Every year 14 million Americans are infected with the sexually-transmitted HPV virus. What the public has been told about the benefits of the HPV vaccination seems to rest on a number of unproven assumptions and incomplete data. For example, the general public has...
by APFLI | Jun 7, 2015 | Right to Life - Archive
Since the introduction and widespread use of the Papanicolaou (Pap) test in the 1950s in the United States, cervical cancer incidence and mortality have decreased dramatically (1,2). In addition to screening with a Pap test alone every 3 years, recent cervical cancer...
by APFLI | Jan 23, 2015 | Right to Life - Archive, Studies - General Research
In 2013, the age-adjusted cervical cancer [malignant neoplasm of cervix uteri] death rate was 2.3 per 100,000. The rate for non-Hispanic black females was nearly double the rate for non-Hispanic white females (4.0 compared to 2.1) and 1.6 higher than the rate of 2.5...
by APFLI | Apr 25, 2014 | Vaccines
Vaccines Do Not Cover Most Common HPV Types in Black Women Advice to Clinicians: Look Beyond HPV 16 and HPV 18 October 28, 2013, Nick Mulcahy, The HPV subtypes that are most common in black women in the United States are not targeted by the currently available...
